A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(272 sites)

United States

Ironwood Cancer & Research Centers, Chandler, Arizona

The University of Arizona Cancer Center, Tucson, Arizona

Roche Tissue Diagnostics, Companion Diagnostics, Tucson, Arizona

Los Angeles Cancer Network, Anaheim, California

Toi Clinical Research, Cerritos, California